サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427890

マラリア治療の世界市場レポート 2024

Malaria Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マラリア治療の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

マラリア治療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.5%の年間複合成長率（CAGR）で19億4,000万米ドルに成長すると予想されます。予測期間中に予測される拡大は、薬剤耐性のモニタリング、気候変動の影響、精密医療とゲノムアプローチの採用、ヘルスケア金融の改革、デジタルヘルスソリューションの統合などの要因によるものと考えられます。予測期間中に予想される主な動向には、疫学調査の強化、代替医療の統合、マラリアワクチン開発の進歩、データ駆動型の治療プログラムの実施、教育と訓練の取り組みの開始などが含まれます。

予想されるマラリア有病率の急増により、今後数年間でマラリア治療市場の拡大が促進される見込みです。マラリアは、マラリア原虫寄生虫によって引き起こされる潜在的に生命を脅かす蚊媒介疾患であり、繰り返しの発熱やインフルエンザなどの症状を示します。このマラリア症例数の増加は、貧困、ヘルスケアサービスへのアクセスの制限、気候変動、強力なマラリア対策の欠如、薬剤耐性の出現などの要因に起因しています。 マラリア治療は、Plasmodium寄生虫によって引き起こされる感染症を効果的に管理および治療する上で極めて重要な役割を果たします。

マラリア治療市場の成長は、ヘルスケア支出の増大によって促進されています。ヘルスケア支出は、特定の地域、国、または組織内のヘルスケア部門に割り当てられる全体的な財源を指し、病気の蔓延を効率的に管理および防止するのに役立ちます。これには、タイムリーな診断、抗マラリア薬、予防策へのアクセスを確保することが含まれます。わかりやすい例として、2023年3月の米国医師会の報告書では、2021年の米国の医療支出が2.7%増加し、4兆3,000億米ドル（一人当たり1万2,914米ドルに相当）に達することが明らかになりました。したがって、ヘルスケア支出の急増は、予見可能な将来におけるマラリア治療市場の成長を促進する主要な推進力となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のマラリア治療市場、治療別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 処方薬
  • ワクチン
  • 診断検査
  • その他の治療法
  • 世界のマラリア治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • オーラル
  • 非経口
  • 静脈内
  • 世界のマラリア治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 直接入札
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他の流通チャネル
  • 世界のマラリア治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • 在宅ケア
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界のマラリア治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のマラリア治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • マラリア治療市場の競合情勢
  • マラリア治療市場の企業プロファイル
    • Pfizer Inc.
    • Merck &Co.
    • Johnson &Johnson
    • Roche Holding AG
    • Bayer AG

第31章 その他の大手および革新的な企業

  • Novartis AG
  • Sanofi SA
  • AstraZeneca Plc
  • GlaxoSmithKline PLC.
  • Takeda Pharmaceutical Company Limited
  • Sumitomo Chemical Co. Ltd.
  • Viatris Inc.
  • Mylan NV
  • Sandoz International GmbH
  • Eisai Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Serum Institute of India
  • Cipla Ltd.
  • Amneal Pharmaceuticals LLC
  • Lupin Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13734

Malaria treatment encompasses the medical interventions and procedures aimed at diagnosing, managing, and curing malaria, a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite.

The primary components of malaria treatment include prescription medications, vaccines, diagnostic tests, and other therapeutic approaches. Prescription medications are pharmaceuticals that require a valid prescription from a healthcare professional. In the context of malaria treatment, these drugs are essential for providing targeted and regulated therapy to combat the infection. They can be administered through oral, parenteral, and intravenous routes and are distributed through various channels such as direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. These channels serve hospitals, specialty clinics, home care settings, and other end users, ensuring a comprehensive reach for malaria treatment options.

The malaria treatment market research report is one of a series of new reports from The Business Research Company that provides malaria treatment market statistics, including malaria treatment industry global market size, regional shares, competitors with a malaria treatment market share, detailed malaria treatment market segments, market trends and opportunities, and any further data you may need to thrive in the malaria treatment industry. This malaria treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The malaria treatment market size has grown strongly in recent years. It will grow from $1.49 billion in 2023 to $1.57 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth observed in the historic period can be attributed to several key factors. These include the discovery of effective drugs for treating malaria, concerted efforts in vector control, global health initiatives aimed at combating malaria, advancements in scientific research contributing to better understanding and treatment options, and the development of health infrastructure to support malaria prevention and treatment efforts. Collectively, these factors played a crucial role in fostering growth and progress in addressing the challenges posed by malaria during the historical period.

The malaria treatment market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The projected expansion during the forecast period can be ascribed to factors such as the monitoring of drug resistance, the impact of climate change, the adoption of precision medicine and genomic approaches, reforms in healthcare financing, and the integration of digital health solutions. Key trends anticipated during the forecast period encompass enhancements in epidemiological surveillance, the integration of alternative medicine, advancements in malaria vaccine development, the implementation of data-driven treatment programs, and the initiation of education and training initiatives.

The anticipated surge in the prevalence of malaria is poised to drive the expansion of the malaria treatment market in the coming years. Malaria, a potentially life-threatening mosquito-borne ailment caused by the Plasmodium parasite, manifests with recurrent fever and flu-such as symptoms. This upswing in malaria cases is attributable to factors such as poverty, limited access to healthcare services, climate change, absence of robust malaria control measures, and emerging drug resistance. Malaria treatment plays a pivotal role in effectively managing and curing infections caused by the Plasmodium parasite.

The growth of the malaria treatment market is bolstered by the escalation in healthcare spending. Healthcare spending, denoting the overall financial resources allocated to the healthcare sector within a specific region, country, or organization, is instrumental in efficiently managing and preventing the proliferation of the disease. This involves ensuring access to timely diagnosis, antimalarial medications, and preventive measures. As an illustrative example, a report from the American Medical Association in March 2023 revealed a 2.7% increase in health spending in the United States in 2021, reaching $4.3 trillion, equivalent to $12,914 per capita. Consequently, the upsurge in healthcare spending is a key driver fueling the growth of the malaria treatment market in the foreseeable future.

The malaria treatment market is witnessing a notable trend with the emergence of novel diagnostic technologies, a development gaining traction among companies in the industry. To maintain their competitive edge, companies in the malaria treatment market are increasingly embracing innovative diagnostic malaria detection technologies. An example is Sysmex America Inc., a US-based developer and manufacturer of automated diagnostic technology, which introduced the XN-30 in October 2021. This automated hematology analyzer incorporates features such as a violet laser, specialized reagents, and advanced algorithms, enabling the differentiation of malarial strains such as P. falciparum and non-falciparum species, along with understanding their life cycle staging. Such advancements in detection contribute to the effective management of malaria treatment and patient recovery.

Major players in the malaria treatment market are adopting a strategic partnership approach to expedite the elimination of relapsing P. vivax malaria. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. An illustrative example is the collaboration between PATH, a US-based nonprofit global health organization, and Medicines for Malaria Venture (MMV), a Switzerland-based foundation specializing in antimalarial drug research and development. This partnership aims to advance the development of quality-assured, child-friendly treatments for relapse prevention, generate evidence to support malaria-endemic countries in developing and implementing new strategies for P. vivax malaria elimination, and promote the development and availability of quality-assured medicines and diagnostics for P. vivax.

In November 2022, Novartis AG, a Switzerland-based pharmaceutical and healthcare company, joined forces with Medicines for Malaria Venture to conduct phase III clinical trials for a novel ganaplacide and lumefantrine-SDF medication combination targeting malaria in both adults and children. Medicines for Malaria Venture (MMV), as a Switzerland-based non-profit organization focused on antimalarial drug research and development, underscores the collaborative efforts within the industry to advance malaria treatment solutions.

Major companies operating in the malaria treatment market report are Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC., Takeda Pharmaceutical Company Limited, Sumitomo Chemical Co. Ltd., Viatris Inc., Mylan N.V., Sandoz International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Zydus Lifesciences Ltd., Medicines Sans Frontieres (Doctors Without Borders), Strides Pharma Science Limited, Swiss Tropical and Public Health Institute (Swiss TPH), Aprecia Pharmaceuticals LLC, AdvaCare Pharma USA LLC, Medicines for Malaria Venture (MMV), VLP Therapeutics LLC, Actiza Pharmaceutical Private Limited

Middle East and Africa was the largest region in the malaria treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the malaria treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The malaria treatment market consists of sales of antimicrobial medications, antimalarial drugs, antipyretics, intravenous fluids, and supportive care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Malaria Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on malaria treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for malaria treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The malaria treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Treatment: Prescription Medications; Vaccines; Diagnostic Tests; Other Treatments
  • 2) By Route of Administration: Oral; Parenteral; Intravenous
  • 3) By Distribution Channel: Direct Tender; Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
  • 4) By End User: Hospitals; Specialty Clinics; Homecare; Other End Users
  • Companies Mentioned: Pfizer Inc.; Merck & Co.; Johnson & Johnson; Roche Holding AG; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Malaria Treatment Market Characteristics

3. Malaria Treatment Market Trends And Strategies

4. Malaria Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Malaria Treatment Market Size and Growth

  • 5.1. Global Malaria Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Malaria Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Malaria Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Malaria Treatment Market Segmentation

  • 6.1. Global Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prescription Medications
  • Vaccines
  • Diagnostic Tests
  • Other Treatments
  • 6.2. Global Malaria Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Intravenous
  • 6.3. Global Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Direct Tender
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels
  • 6.4. Global Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End Users

7. Malaria Treatment Market Regional And Country Analysis

  • 7.1. Global Malaria Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Malaria Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Malaria Treatment Market

  • 8.1. Asia-Pacific Malaria Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Malaria Treatment Market

  • 9.1. China Malaria Treatment Market Overview
  • 9.2. China Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Malaria Treatment Market

  • 10.1. India Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Malaria Treatment Market

  • 11.1. Japan Malaria Treatment Market Overview
  • 11.2. Japan Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Malaria Treatment Market

  • 12.1. Australia Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Malaria Treatment Market

  • 13.1. Indonesia Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Malaria Treatment Market

  • 14.1. South Korea Malaria Treatment Market Overview
  • 14.2. South Korea Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Malaria Treatment Market

  • 15.1. Western Europe Malaria Treatment Market Overview
  • 15.2. Western Europe Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Malaria Treatment Market

  • 16.1. UK Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Malaria Treatment Market

  • 17.1. Germany Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Malaria Treatment Market

  • 18.1. France Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Malaria Treatment Market

  • 19.1. Italy Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Malaria Treatment Market

  • 20.1. Spain Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Malaria Treatment Market

  • 21.1. Eastern Europe Malaria Treatment Market Overview
  • 21.2. Eastern Europe Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Malaria Treatment Market

  • 22.1. Russia Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Malaria Treatment Market

  • 23.1. North America Malaria Treatment Market Overview
  • 23.2. North America Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Malaria Treatment Market

  • 24.1. USA Malaria Treatment Market Overview
  • 24.2. USA Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Malaria Treatment Market

  • 25.1. Canada Malaria Treatment Market Overview
  • 25.2. Canada Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Malaria Treatment Market

  • 26.1. South America Malaria Treatment Market Overview
  • 26.2. South America Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Malaria Treatment Market

  • 27.1. Brazil Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Malaria Treatment Market

  • 28.1. Middle East Malaria Treatment Market Overview
  • 28.2. Middle East Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Malaria Treatment Market

  • 29.1. Africa Malaria Treatment Market Overview
  • 29.2. Africa Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Malaria Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Malaria Treatment Market Competitive Landscape
  • 30.2. Malaria Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Johnson & Johnson
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Roche Holding AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bayer AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Malaria Treatment Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Sanofi SA
  • 31.3. AstraZeneca Plc
  • 31.4. GlaxoSmithKline PLC.
  • 31.5. Takeda Pharmaceutical Company Limited
  • 31.6. Sumitomo Chemical Co. Ltd.
  • 31.7. Viatris Inc.
  • 31.8. Mylan N.V.
  • 31.9. Sandoz International GmbH
  • 31.10. Eisai Co. Ltd.
  • 31.11. Sun Pharmaceutical Industries Ltd.
  • 31.12. Serum Institute of India
  • 31.13. Cipla Ltd.
  • 31.14. Amneal Pharmaceuticals LLC
  • 31.15. Lupin Ltd.

32. Global Malaria Treatment Market Competitive Benchmarking

33. Global Malaria Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Malaria Treatment Market

35. Malaria Treatment Market Future Outlook and Potential Analysis

  • 35.1 Malaria Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Malaria Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Malaria Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer